Search

Author/Creator Fabikan, Hannah

2. Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer. (July 2019)

Authors:
Beer, Lucian; Hochmair, Maximilian; Haug, Alexander R.; Schwabel, Bernhard; Kifjak, Daria; Wadsak, Wolfgang; Fuereder, Thorsten; Fabikan, Hannah; Fazekas, Andreas; Schwab, Sophia; Mayerhoefer, Marius E.; Herold, Christian; Prosch, Helmut
Journal:
Clinical nuclear medicine
Issue:
Volume 44:Number 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients. (February 2021)

Authors:
Hackner, Klaus; Buder, Anna; Hochmair, Maximilian J; Strieder, Matthaeus; Grech, Christina; Fabikan, Hannah; Burghuber, Otto C.; Errhalt, Peter; Filipits, Martin
Journal:
Clinical medicine insights. Oncology
Issue:
Volume 15(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program. (June 2022)

Authors:
Illini, Oliver; Fabikan, Hannah; Swalduz, Aurélie; Vikström, Anders; Krenbek, Dagmar; Schumacher, Michael; Dudnik, Elizabeth; Studnicka, Michael; Öhman, Ronny; Wurm, Robert; Wannesson, Luciano; Peled, Nir; Kian, Waleed; Bar, Jair; Daher, Sameh; Addeo, Alfredo; Rotem, Ofer; Pall, Georg; Zer, Alona...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program. (June 2021)

Authors:
Illini, Oliver; Hochmair, Maximilian Johannes; Fabikan, Hannah; Weinlinger, Christoph; Tufman, Amanda; Swalduz, Aurélie; Lamberg, Kristina; Hashemi, Sayed M. S.; Huemer, Florian; Vikström, Anders; Wermke, Martin; Absenger, Gudrun; Addeo, Alfredo; Banerji, Shantanu; Calles, Antonio; Clarke, Stephe...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution. Issue 7 (August 2019)

Authors:
Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; Naber, Jakob; Setinek, Ulrike; Krenbek, Dagmar; Urban, Matthias H.; Fabikan, Hannah; Watzka, Stefan; Koger, Renate; Fazekas, Andreas; Bitterlich, Erwin; Valipour, Arschang; Burghuber, Otto C.
Journal:
Anti-cancer drugs
Issue:
Volume 30:Issue 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗